Romosozumab not only enhanced bone mineral density but also improve back pain and life quality
Main Authors: | Chung-Hwan Chen, Sung-Yen Lin, Tien-Ching Lee, Cheng-Jung Ho, Jhong-You Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-12-01
|
Series: | Osteoporosis and Sarcopenia |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405525523001024 |
Similar Items
-
Romosozumab Followed by Antiresorptive Treatment Increases the Probability of Achieving Bone Mineral Density Treatment Goals
by: Felicia Cosman, et al.
Published: (2021-11-01) -
Features of the course and treatment of low back pain in patients with reduced bone mineral density
by: N. M. Shuba, et al.
Published: (2020-09-01) -
Comparative analysis of denosumab, romosozumab, and teriparatide effects on bone density and structural integrity in osteoporotic vertebral compression fractures
by: T. Goh, et al.
Published: (2024-01-01) -
EGPA Phenotyping: Not Only ANCA, but Also Eosinophils
by: Andrea Matucci, et al.
Published: (2023-03-01) -
Romosozumab in osteoporosis: yesterday, today and tomorrow
by: Dong Wu, et al.
Published: (2023-09-01)